Cambridge Investment Research Advisors’s FT Vest Nasdaq-100 Moderate Buffer ETF - February QMFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$441K Sell
18,156
-24,720
-58% -$588K ﹤0.01% 3084
2026
Q1
$951K Sell
42,876
-4,152
-9% -$93.3K ﹤0.01% 2214
2025
Q4
$1.05M Sell
47,028
-11,469
-20% -$251K ﹤0.01% 2058
2025
Q3
$1.27M Buy
58,497
+1,421
+2% +$30.1K ﹤0.01% 1864
2025
Q2
$1.18M Buy
57,076
+26,410
+86% +$517K ﹤0.01% 1821
2025
Q1
$582K Buy
+30,666
New +$593K ﹤0.01% 2290

Other funds holding QMFE

Cambridge Investment Research Advisors's QMFE Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its FT Vest Nasdaq-100 Moderate Buffer ETF - February (QMFE) stake by 58% in Q2 2026, selling an estimated $588K and leaving 18,156 shares worth $441K. The position accounts for ﹤0.01% of the portfolio, ranked #3084.

Cambridge Investment Research Advisors first reported a position in QMFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.27M in Q3 2025. 13 funds tracked by Wall St. Rank hold QMFE as of Q2 2026.

  • Cambridge Investment Research Advisors held 18,156 shares of FT Vest Nasdaq-100 Moderate Buffer ETF - February worth $441K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 24,720 FT Vest Nasdaq-100 Moderate Buffer ETF - February shares in Q2 2026, an estimated $588K.
  • FT Vest Nasdaq-100 Moderate Buffer ETF - February made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3084 holding.
  • Cambridge Investment Research Advisors first reported a position in FT Vest Nasdaq-100 Moderate Buffer ETF - February in Q1 2025 and has held it in 6 quarters since.
  • Cambridge Investment Research Advisors's FT Vest Nasdaq-100 Moderate Buffer ETF - February position peaked at $1.27M in Q3 2025.
  • 13 funds tracked by Wall St. Rank held FT Vest Nasdaq-100 Moderate Buffer ETF - February as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.